1. Home
  2. ALG vs KARD Comparison

ALG vs KARD Comparison

Compare ALG & KARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alamo Group Inc.

ALG

Alamo Group Inc.

HOLD

Current Price

$167.95

Market Cap

1.9B

Sector

Industrials

ML Signal

HOLD

Logo Kardigan Inc. Common Stock

KARD

Kardigan Inc. Common Stock

N/A

Current Price

$18.62

Market Cap

1.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ALG
KARD
Founded
1955
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.9B
IPO Year
1996
2026

Fundamental Metrics

Financial Performance
Metric
ALG
KARD
Price
$167.95
$18.62
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$225.00
N/A
AVG Volume (30 Days)
137.1K
250.5K
Earning Date
05-04-2026
N/A
Dividend Yield
0.81%
N/A
EPS Growth
N/A
N/A
EPS
4.96
N/A
Revenue
$1,603,715,000.00
N/A
Revenue This Year
$5.26
N/A
Revenue Next Year
$3.97
N/A
P/E Ratio
$34.60
N/A
Revenue Growth
N/A
N/A
52 Week Low
$145.76
$19.41
52 Week High
$219.88
$27.00

Technical Indicators

Market Signals
Indicator
ALG
KARD
Relative Strength Index (RSI) 52.03 40.58
Support Level $167.49 N/A
Resistance Level $172.00 $22.61
Average True Range (ATR) 4.96 1.37
MACD 0.54 -0.09
Stochastic Oscillator 50.38 1.39

Price Performance

Historical Comparison
ALG
KARD

About ALG Alamo Group Inc.

Alamo Group Inc is engaged in the design, manufacture, and servicing of high-quality vegetation management and infrastructure maintenance equipment for governmental, industrial, and agricultural use. Its products include agricultural implements, tree and branch chippers, forestry/wood recycling equipment, street and parking lot sweepers, leaf and debris collection equipment, truck-mounted highway attenuator trucks, vacuum trucks, hydro-excavation equipment, telescopic boom excavators, snow removal equipment, etc. The company's reportable segments are Vegetation Management, which generates the maximum revenue, and Industrial Equipment. Geographically, the company generates maximum revenue from the United States, followed by Canada, France, the UK, Brazil, the Netherlands, and other regions.

About KARD Kardigan Inc. Common Stock

Kardigan Inc is a clinical-stage therapeutics company focused on developing medicines for cardiovascular diseases. Its activities include the research and development of targeted therapies for cardiovascular conditions for which no approved treatments currently exist. The company's clinical-stage programs include Danicamtiv, Ataciguat, and Tonlamarsen, which are being developed for cardiovascular disease indications. The company operates and manages its business as a single operating and reportable segment, focused on the discovery and development of novel therapeutic products to treat cardiovascular disease.

Share on Social Networks: